GNP-GAPDH1-22 formulated with Advax, while showing listeriosis protection in brains (2-3 CFU/mL), failed to reduce liver LMWT (400 CFU/ml) and produced anti-GAPDH1-22 antibodies, while produced high IL-10 levels (Table 4). This evidence concerns the gene IL10 and listeriosis.